SUNSHINE BIOPHARMA AND BINGHAMTON UNIVERSITY (STATE UNIVERSITY OF NEW[...]
SUNSHINE BIOPHARMA’S LEAD ANTI CANCER COMPOUND, ADVA 27A, PERFORMS[...]
SUNSHINE BIOPHARMA’S CEO DOES LIVE INTERVIEW ON CHARTPOPPERS.COM
16/11/2022 | Press release | Archived content
Please select the service you want to use:
Smartlinks | Sunshine Biopharma Inc. | News | Health | Biotechnology | Technology | Biotechnology | Science | Biotechnology | Research | Company News | Top Company News | Business Announcement | Mining | Pharmaceuticals | Securities Issuers | Pharmaceutical Companies | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | FINRA Alternative Display Facility (ADF) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact